About IGF-1LR3
IGF-1LR3 is a synthetic insulin-like growth factor-1 peptide analogue specifically engineered for extended research applications. This modified peptide variant incorporates amino acid substitutions that significantly extend its biological half-life compared to native IGF-1, making it particularly valuable for controlled laboratory investigations. Researchers at Stroid UK Shop can access this premium-grade compound to examine cellular growth factor pathways, protein synthesis mechanisms, and anabolic signalling cascades in controlled experimental environments. The Hubio Pharm formulation ensures consistent molecular integrity across research protocols.
Research Applications
In laboratory settings, scientists investigate IGF-1LR3’s interaction with IGF-1 receptors and subsequent activation of downstream signalling pathways including PI3K/Akt and MAPK cascades. Research models examine its effects on cellular proliferation, differentiation, and metabolic processes in various tissue types. The extended half-life characteristics allow for sustained receptor binding studies and prolonged experimental observation periods. Comparative studies with other peptides help elucidate growth factor mechanisms, while researchers investigating anabolic pathways often examine IGF-1LR3 alongside SARMs for comprehensive pathway analysis. Advanced research protocols evaluate its role in cellular energy metabolism and protein synthesis regulation.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | IGF-1LR3 (Long R3 Insulin-like Growth Factor-1) |
| Manufacturer | Hubio Pharm |
| Net Content | 1mg lyophilised powder |
| Molecular Weight | Approximately 9.1 kDa |
| CAS Number | Verify with supplier |
| Storage Conditions | -20°C (lyophilised), 2-8°C (reconstituted) |
| Purity | Research grade |
| Research Applications | Growth factor pathway studies |
Research Storage and Handling
Maintain lyophilised IGF-1LR3 powder at -20°C in original sealed vials to preserve molecular stability throughout extended research programmes. Upon reconstitution with appropriate sterile diluents, store solutions at 2-8°C and utilise within recommended timeframes to ensure experimental consistency. Protect from direct light exposure and avoid repeated freeze-thaw cycles that may compromise peptide integrity. Laboratory personnel should follow established biosafety protocols when handling research compounds. Research facilities investigating peptide formulations often source complementary compounds from our IGF-1 peptide category for comparative analysis.
Important: IGF-1LR3 1mg Hubio Pharm is manufactured strictly for in-vitro research purposes only. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with institutional guidelines and local regulations governing peptide research compounds.
